Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency (EMA) has validated a Type II variation application to the Marketing Authorization for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor. The application…
Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the launch of its state-of-the-art Electronic Health Record (EHR) integration for its cutting-edge diabetes data visualization…
EVOLVE MVMT, a first-of-its-kind wearable that aims to optimize human movement through walking, is the first to analyze not just quantity, but quality, of steps. EVOLVE MVMT enables users to…
BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing Today BIOVECTRA celebrates the completion of its $90 million plus biologics expansion at the company’s new state-of-the-art Biomanufacturing Centre…
Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation…
Lunovus Enhances Its Eyecare Software and Service Solutions with Acquisition of Diamond Studios Lunovus LLC, a physician-owned pioneer in the eyecare industry, known for its advanced medical software and eye…
Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for…
Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two studies showcasing vMap®’s novel application in the analysis and treatment of ventricular arrhythmias. Both studies are…
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported…
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and…
Histosonics ( www.histosonics.com ), the non-invasive Edison® Histotripsy System and innovative sound wave therapy, is a Medicare – The Centers for Medicaid Services (CMS) announced a new subsidy of $17,500 for histotripsy…
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new discovery data from an ongoing study exploring the potential for developing…